نتائج البحث - Barbara Pro

تنقيح النتائج
  1. 1
    Central nervous system prophylaxis in peripheral T-cell lymphoma

    Central nervous system prophylaxis in peripheral T-cell lymphoma حسب Barbara Pro, Guilherme Fleury Perini

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Brentuximab Vedotin in CD30+ Lymphomas

    Brentuximab Vedotin in CD30+ Lymphomas حسب Guilherme Fleury Perini, Barbara Pro

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    How I treat posttransplant lymphoproliferative disorder

    How I treat posttransplant lymphoproliferative disorder حسب Jennifer E. Amengual, Barbara Pro

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Hepatosplenic T-cell lymphoma: a rare but challenging entity

    Hepatosplenic T-cell lymphoma: a rare but challenging entity حسب Barbara Pro, Pamela B. Allen, Amir Behdad

    منشور في 2020
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Meta–analyses of the association between <i>Chlamydia psittaci</i> and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics

    Meta–analyses of the association between <i>Chlamydia psittaci</i> and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics حسب Amina Husain, Dianna Roberts, Barbara Pro, Peter McLaughlin, Bita Esmaeli

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

    Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial حسب Francine M. Foss, Sarah McCue Horwitz, Barbara Pro, H. Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature

    Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature حسب Andres O. Soriano, Michael A. Thompson, Joan H. Admirand, Luis Fayad, Alma María Rodríguez, Jorge Romaguera, Fredrick B. Hagemeister, Barbara Pro

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

    Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment حسب G. S. Falchook, Francisco Vega, Nam H. Dang, Felipe Samaniego, Maria Alma Rodriguez, Richard E. Champlin, Chitra Hosing, Srđan Verstovšek, Barbara Pro

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma حسب Yasuhiro Oki, Barbara Pro, Luis Fayad, Jorge Romaguera, Felipe Samaniego, Fredrick Hagemeister, Sattva S. Neelapu, Peter McLaughlin, André Goy, Anas Younes

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma

    Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma حسب Elias Jabbour, Chitra Hosing, Gregory D. Ayers, Rodolfo Núñez, Paolo Anderlini, Barbara Pro, Issa F. Khouri, Anas Younes, Fredrick B. Hagemeister, Larry W. Kwak, Luis Fayad

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma

    Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma حسب Jia Ruan, Jasmine M. Zain, Brett Alan Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N. Winter, Leo I. Gordon, Reem Karmali, Jonathan Moreira, Adam M. Petrich, Barbara Pro

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

    Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma حسب Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy

    Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy حسب Maria Estela Martínez‐Escala, Alba Posligua, Heather Wickless, Audrey Rutherford, Kimberly A. Sable, Belén Rubio-González, Xiaolong Zhou, Jason Kaplan, Barbara Pro, Jaehyuk Choi, Christiane Querfeld, Steven T. Rosen, Joan Guitart

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma treatment (COMPLETE) registry

    Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma tre... حسب Robert Stuver, Niloufer Khan, Marc Schwartz, Mark Acosta, Massimo Federico, Christian Gisselbrecht, Steven M. Horwitz, Frederik Lansigan, Lauren Pinter‐Brown, Barbara Pro, Andrei R. Shustov, Francine M. Foss, Salvia Jain

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma

    Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma حسب Barbara Pro, Brian Leber, Mitchell R. Smith, Luis Fayad, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James A. Zwiebel, Adriana López, Larry W. Kwak, Anas Younes

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study

    Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study حسب Michelle A. Fanale, Steven M. Horwitz, Andres Forero‐Torres, Nancy L. Bartlett, Ranjana H. Advani, Barbara Pro, Robert W. Chen, Andrew Davies, Tim Illidge, Dirk Huebner, Dana A. Kennedy, Andrei R. Shustov

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma حسب Michael Wang, Yasuhiro Oki, Barbara Pro, Jorge Romaguera, Maria Alma Rodriguez, Felipe Samaniego, Peter McLaughlin, Frederick Hagemeister, Sattva S. Neelapu, Amanda Copeland, Barry I. Samuels, Evelyne M. Loyer, Yuan Ji, Anas Younes

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease

    Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease حسب Amer Beitinjaneh, Rima M. Saliba, L. Jeffrey Medeiros, Francesco Turturro, Gabriela Rondón, Martin Körbling, Luis Fayad, Michelle A. Fanale, Amin M. Alousi, Paolo Anderlini, Betül Oran, Uday Popat, Barbara Pro, Issa F. Khouri

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients

    Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients حسب Maria L. Espinosa, Morgan Nguyen, Amaia Saenz Aguirre, Maria Estela Martínez‐Escala, Jane Kim, Christina J. Walker, David Pontes, Jonathan I. Silverberg, Jaehyuk Choi, Barbara Pro, Laura B. Pincus, Joan Guitart, Xiaolong Zhou

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

    Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium حسب Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott E. Smith, Patrick J. Stiff, Eric P. Lester, Sanjiv Modi, L. Austin Doyle, Everett E. Vokes, Barbara Pro

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: